Status:

COMPLETED

Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More

Lead Sponsor:

Central Jutland Regional Hospital

Conditions:

Ketosis

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

his study aims to address two key aspects - part 1: the suitability of selecting a specific sampling site for BHB measurement in patients and research, as well as potential differences between capilla...

Detailed Description

Aim and Perspective: The primary objective of this study - part 1 - is to ascertain: The agreement between estimates of beta-hydroxybutyrate (BHB) in capillary and venous blood and whether this agre...

Eligibility Criteria

Inclusion

  • Age 18-60 years
  • BMI 19-30 kg/m2
  • Expected ease of catheter insertion
  • Considered of sound health
  • Oral and written informed consent

Exclusion

  • Inability to fully understand the consent including consent forms
  • Inability to cooperate to the study
  • electrolyte disorders
  • acute or chronic kidney disease or ompromised renal function including excess risk
  • servere hypertension
  • autoimmune disease
  • liver or bile disease
  • diabetes mellitus
  • reactive hypoglycemia or similar disorders
  • treatment with drugs, and dietary supplements with inference on key metabolic or hormonal markers, e.g. insulin, glucagon, DDP-IV inhibitors, GLP-1 RA, sulfunylurea
  • use of illegal or otherwise use of medicinal products without prescription
  • anemia or other know disease of the hematopoietic system
  • previous bariatric surgery
  • previous myocardial infarction or uncontrolled myocardial ischemia
  • recent intended/unintended weight loss
  • allergies to catheters or adhesives

Key Trial Info

Start Date :

August 24 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 30 2024

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT06053138

Start Date

August 24 2023

End Date

August 30 2024

Last Update

April 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Internal Medicine, Viborg Regional Hospital

Viborg, Denmark, 8800

Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More | DecenTrialz